Clinical trial

The Effect of Post-surgical Chlorhexidine Mouth Washing on the Sub-gingival Periodontal Microbiome; a Pilot Study

Name
0694-21-RMB CTIL
Description
Prospective applicants who conform with inclusion and exclusion criteria will be accepted into the study and sign a consent form. Visit 1: After initial screening a case report form (CRF) will be filled, including information regarding general health, medication, demographic, oral and dental information. Participants will be clinically examined and the following data will be collected prior to surgery: microbial collection, Plaque score (PS) , probing pocket depth (PPD), bleeding on probing (BOP) at selected non-surgical and surgical teeth. Surgery will be performed followed by discharge with a bottle of chlorhexidine mouthwash and written instructions on its usage. Visit 2: Ten days after surgery sutures will be removed and collected for microbial examination. Microbial collection will be performed at non-surgical and surgical sites. Adverse events will be recorded and participants will be discharged from the study.
Trial arms
Trial start
2023-02-03
Estimated PCD
2024-06-10
Trial end
2024-06-25
Status
Recruiting
Treatment
Corsodyl
Corsodyl (a chlorhexidine mouthwash) will be used to rinse the mouth for one minute with 10 ml twice daily during ten days after oral surgery
Other names:
Chlorhexidine mouthwash
Size
30
Primary endpoint
alpha and beta diversity
10-14 days
Eligibility criteria
Inclusion Criteria: * Signed Informed Consent Form * Age ≥18 years * Scheduled for periodontal/dental surgery without pre- and/or post-surgical antibiotic therapy Exclusion Criteria: * Pre-existing conditions that may affect the microbiome, including diagnoses of diabetes, malignancy, alcoholism, previous head and neck radiation therapy * Pregnancy and breast-feeding * Chronic medications that are known to affect periodontal tissues such as Ca channel blockers and phenytoin * Antibiotic therapy within the previous 6 weeks * Mouthwash therapy within the previous 2 weeks * Known allergy to CM or any of its constituents * Smoking \>10 cigarettes/day
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'CASE_ONLY', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 30, 'type': 'ESTIMATED'}}
Updated at
2023-03-30

1 organization

1 product

2 indications

Product
Corsodyl
Indication
periodontitis